PMC:7258756 / 4375-4584
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"100","span":{"begin":7,"end":11},"obj":"Gene"},{"id":"101","span":{"begin":180,"end":184},"obj":"Gene"},{"id":"102","span":{"begin":118,"end":123},"obj":"Gene"},{"id":"104","span":{"begin":57,"end":66},"obj":"Species"},{"id":"105","span":{"begin":107,"end":117},"obj":"Species"},{"id":"112","span":{"begin":192,"end":197},"obj":"Species"},{"id":"113","span":{"begin":201,"end":206},"obj":"Species"}],"attributes":[{"id":"A100","pred":"tao:has_database_id","subj":"100","obj":"Gene:59272"},{"id":"A101","pred":"tao:has_database_id","subj":"101","obj":"Gene:59272"},{"id":"A102","pred":"tao:has_database_id","subj":"102","obj":"Gene:43740568"},{"id":"A104","pred":"tao:has_database_id","subj":"104","obj":"Tax:694009"},{"id":"A105","pred":"tao:has_database_id","subj":"105","obj":"Tax:2697049"},{"id":"A112","pred":"tao:has_database_id","subj":"112","obj":"Tax:9606"},{"id":"A113","pred":"tao:has_database_id","subj":"113","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"yme 2 (ACE2) has been identified as the receptor for the SARS-CoVs10. Specific mutations in the RBD of the SARS-CoV-2 spike glycoprotein were found to have enhanced binding to the ACE211.\nThe human-to-human tr"}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T22","span":{"begin":124,"end":136},"obj":"Body_part"}],"attributes":[{"id":"A22","pred":"fma_id","subj":"T22","obj":"http://purl.org/sig/ont/fma/fma62925"}],"text":"yme 2 (ACE2) has been identified as the receptor for the SARS-CoVs10. Specific mutations in the RBD of the SARS-CoV-2 spike glycoprotein were found to have enhanced binding to the ACE211.\nThe human-to-human tr"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T39","span":{"begin":57,"end":61},"obj":"Disease"},{"id":"T40","span":{"begin":107,"end":115},"obj":"Disease"},{"id":"T41","span":{"begin":107,"end":111},"obj":"Disease"}],"attributes":[{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A41","pred":"mondo_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"yme 2 (ACE2) has been identified as the receptor for the SARS-CoVs10. Specific mutations in the RBD of the SARS-CoV-2 spike glycoprotein were found to have enhanced binding to the ACE211.\nThe human-to-human tr"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T51","span":{"begin":13,"end":16},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T52","span":{"begin":192,"end":197},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T53","span":{"begin":201,"end":206},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"yme 2 (ACE2) has been identified as the receptor for the SARS-CoVs10. Specific mutations in the RBD of the SARS-CoV-2 spike glycoprotein were found to have enhanced binding to the ACE211.\nThe human-to-human tr"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T12","span":{"begin":124,"end":136},"obj":"Chemical"}],"attributes":[{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"}],"text":"yme 2 (ACE2) has been identified as the receptor for the SARS-CoVs10. Specific mutations in the RBD of the SARS-CoV-2 spike glycoprotein were found to have enhanced binding to the ACE211.\nThe human-to-human tr"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T37","span":{"begin":70,"end":187},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"yme 2 (ACE2) has been identified as the receptor for the SARS-CoVs10. Specific mutations in the RBD of the SARS-CoV-2 spike glycoprotein were found to have enhanced binding to the ACE211.\nThe human-to-human tr"}